Pennsylvania Medicaid spent nearly $300 million on Wegovy and other anti-obesity drugs
Pennsylvania's Medicaid spending per enrollee on Wegovy, Zepbound, and other anti-obesity drugs was third-highest in the nation.
Wegovy is among the GPL-1 obesity drugs that is covered by Pennsylvania Medicaid plans for people who also qualify for Medicare. Read moreGeorge Frey / Bloomberg
